Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 11, 1998, Pages 4116-4122

  Sugg, Sonia L ^b   Ezzat, Shereen ^c   Rosen, Irving B ^c   Freeman, Jeremy L ^c   Asa, Sylvia L ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF CHICAGO   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OCCULT CANCER; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID PAPILLARY CARCINOMA;

MUS MUSCULUS;

EID: 0031792561     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.11.4116     Document Type: Article

References (43)

1. Fusco A, Grieco M, Santoro M, et al. 1987 A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature. 328:170-172.
2. Jhiang SM, Sagartz JE, Tong Q, et al. 1996 Targeted expression of the ret/FTC1 oncogene induces papillary thyroid carcinomas. Endocrinology. 137:375-378.
3. Santoro M, Chiappetta G, Cerrato A, et al. 1996 Development of thyroid papillary carcinomas secondary to tissue- specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene. 12:1821-1826.
4. Sugg SL, Zheng L, Rosen IB, et al. 1996 ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? J Clin Endocrinol Metab. 81:3360-3365.
5. Jhiang SM, Mazzaferri EL. 1994 The ret/PTC oncogene in papillary thyroid carcinoma. [Review]. J Lab Clin Med. 123:331-337.
6. Wajjwalku W, Nakamura S, Hasegawa Y, et al. 1992 Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Jpn J Cancer Res. 83:671-675.
7. Klugbauer S, Lengfelder E, Demidchik EP, et al. 1995 High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene. 11:2459-2467.
8. Nikiforov YE, Rowland JM, Bove KE, et al. 1997 Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 57:1690-1694.
9. Williams GH, Rooney S, Thomas GA, et al. 1996 RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material. Br J Cancer. 74:585-589.
10. Jhiang SM, Caruso DR, Gilmore E, et al. 1992 Detection of the PTC/retTPC oncogene in human thyroid cancers. Oncogene. 7:1331-1337.
11. Mayr B, Brabant G, Goretzki P, et al. 1997 ret/Ptc-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? [letter; comment]. J Clin Endocrinol Metab. 82:1306-1307.
12. Viglietto G, Chiappetta G, Martinez-Tello FJ, et al. 1995 RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene. 11:1207-1210.
13. Fink A, Tomlinson G, Freeman JL, et al. 1996 Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod Pathol. 9:816-820.
14. LiVolsi VA. 1990 Surgical Pathology of the Thyroid. Philadelphia: W. B. Saunders.
15. Raphael SJ, Apel RL, Asa SL. 1995 Brief report: detection of high-molecular-weight cytokeratins in neoplastic and non-neoplastic thyroid tumors using microwave antigen retrieval. Mod Pathol. 8:870-872.
16. Grieco M, Santoro M, Berlingieri MT, et al. 1990 PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell. 60:557-563.
17. Bongarzone I, Monzini N, Borrello MG, et al. 1993 Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Mol Cell Biol. 13:358-366.
18. Santoro M, Dathan NA, Berlingieri MT, et al. 1994 Molecular characterization of RET/PTC3; a novel rearranged version of the RET protooncogene in a human thyroid papillary carcinoma. Oncogene. 9:509-516.
19. Wynford-Thomas D. 1993 In vitro models of thyroid cancer. [Review]. Cancer Surv. 16:115-134.
20. Ezzat S, Zheng L, Kolenda J, et al. 1996 Prevalence of activating ras mutations in morphologically characterized thyroid nodules. Thyroid. 6:409-416.
21. Krohn D, Fuhrer D, Holzapfel H, et al. 1998 Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations. J Clin Endocrinol Metab. 83:180-184.
22. Parma J, Duprez L, Van Sande J, et al. 1997 Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab. 82:2695-2701.
23. Di Renzo MF, Olivero M, Ferro S, et al. 1992 Overexpression of the c-MET/ HGF receptor gene in human thyroid carcinomas. Oncogene. 7:2549-2553.
24. Bongarzone I, Pierotti MA, Monzini N, et al. 1989 High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene. 4:1457-1462.
25. Fagin JA, Matsuo K, Karmakar A, et al. 1993 High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest. 91:179-184.
26. Nishida T, Nakao K, Hamaji M, et al. 1996 Overexpression of p53 protein and DNA content are important biologic prognostic factors for thyroid cancer. Surgery. 119:568-575.
27. Hosal SA, Apel RL, Freeman JL, et al. 1997 Immunohistochemical localization of p53 in human thyroid neoplasms: correlation with biological behavior. Endocr Pathol. 8:21-28.
28. Santoro M, Carlomagno F, Hay ID, et al. 1992 Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest. 89:1517-1522.
29. Ishizaka Y, Shima H, Sugimura T, et al. 1992 Detection of phosphorylated ret/TPC oncogene product in cytoplasm. Oncogene. 7:1441-1444.
30. Pierotti MA, Santoro M, Jenkins RB, et al. 1992 Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc Natl Acad Sci USA. 89:1616-1620.
31. Minoletti F, Butti MG, Coronelli S, et al. 1994 The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2. Genes Chromosom Cancer. 11:51-57.
32. Klugbauer S, Lengfelder E, Demidchik EP, et al. 1996 A new form of RET rearrangement in thyroid carcinomas of children after the Chernobyl reactor accident. Oncogene. 13:1099-1102.
33. Fugazzola L, Pierotti MA, Vigano E, et al. 1996 Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer. Oncogene. 13:1093-1097.
34. Sozzi G, Bongarzone I, Miozzo M, et al. 1994 A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma. Genes Chromosom Cancer. 9:244-250.
35. Klugbauer S, Demidchik EP, Lengfelder E, et al. 1998 Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5. Cancer Res. 58:198-203.
36. Harach HR, Franssila KO, Wasenius VM. 1985 Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer. 56:531-538.
37. Wirtschafter A, Schmidt R, Rosen D, et al. 1997 Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope. 107:95-100.
38. Eng C, Mulligan LM, Healey CS, et al. 1996 Heterogeneous mutation of the RET protooncogene in subpopulations of medullary thyroid carcinoma. Cancer Res. 56:2167-2170.
39. Ott RA, McCall AR, McHenry C, et al. 1987 The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am Surg. 53:442-445.
40. Bond JA, Wyllie FS, Rowson J, et al. 1994 In vitro reconstruction of tumour initiation in a human epithelium. Oncogene. 9:281-290.
41. Teixeira MR, Pandis N, Bardi G, et al. 1997 Discrimination between multicentric and multifocal breast carcinoma by cytogenetic investigation of macroscopically distinct ipsilateral lesions. Genes Chromosom Cancer. 18:170-174.
42. Mirchandani D, Zheng J, Miller GJ, et al. 1995 Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. Am J Pathol. 147:92-101.
43. Goto K, Konomoto T, Hayashi K, et al. 1997 p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas. Mod Pathol. 10:428-437.